Ruiz-Aragón J, García-Agudo L, Flores S, Rodríguez M J, Marín P, García-Martos P
Servicio de Microbiología, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Rev Esp Quimioter. 2007 Dec;20(4):429-32.
Rapidly growing mycobacteria are often associated with human diseases. We investigated the in vitro susceptibilities of 40 isolates to six antimicrobial agents: 17 Mycobacterium fortuitum, 11 M. chelonae and 12 M. abscessus isolated from several human sources: 29 respiratory secretions, 5 cutaneous abscesses, 4 corneal ulcers and 2 urine samples of patients treated at "Hospital Puerta del Mar" (Cádiz). Susceptibility studies were determined by the broth microdilution method for amikacin, clarithromycin, ciprofloxacin, levofloxacin, imipenem and cefoxitin. Results suggest that amikacin is the most effective antimicrobial agent for treating infections due to rapidly growing mycobacteria. Clarithromycin and imipenem show good activity against M. fortuitum and M. abscessus, but not against M. chelonae. Quinolones are only effective against M. fortuitum. It's important to identify, in rapidly growing mycobacteria infections, the etiologic agent to determine correct treatment.
快速生长分枝杆菌常与人类疾病相关。我们研究了40株分离菌株对六种抗菌药物的体外敏感性:从“马尔港医院”(加的斯)接受治疗的患者的多种来源中分离出的17株偶然分枝杆菌、11株龟分枝杆菌和12株脓肿分枝杆菌,这些来源包括29份呼吸道分泌物、5个皮肤脓肿、4个角膜溃疡和2份尿液样本。采用肉汤微量稀释法测定阿米卡星、克拉霉素、环丙沙星、左氧氟沙星、亚胺培南和头孢西丁的敏感性。结果表明,阿米卡星是治疗快速生长分枝杆菌感染最有效的抗菌药物。克拉霉素和亚胺培南对偶然分枝杆菌和脓肿分枝杆菌显示出良好活性,但对龟分枝杆菌无效。喹诺酮类仅对偶然分枝杆菌有效。在快速生长分枝杆菌感染中,识别病原体以确定正确治疗很重要。